*Sign up for our MoneyWise newsletter to receive a steady flow of actionable ideas from Wall Street's top firms.

Gilead Sciences

Gilead Sciences is already one of the more generous dividend-payers from the healthcare sector, currently offering an annual dividend yield of 4.8%. But Goldman sees bigger payouts on the horizon.

The financial juggernaut predicts that by 2023, Gilead’s dividend per share divided by its current price will lead to a yield of 5%.

There’s good reason to be optimistic about this biopharmaceutical company. In Q1, Gilead’s revenue grew 3% year over year to $6.6 billion while adjusted earnings per share increased 4% to $2.12.

It also has a solid cash position of almost $7 billion as of Mar. 31.

Gilead started paying dividends in 2015 with a quarterly payout of 43 cents per share. Today, the company pays 73 cents per share — so the amount has grown by almost 70%.

An app called Acorns automatically rounds up purchases made on your credit or debit card to the nearest dollar and places the excess "change" into a smart investment portfolio. You get $10 immediately from your first investment.

Get $10

Best Buy (BBY)

The past few years haven’t been kind to brick-and-mortar stores. So who would have guessed that electronics retailer Best Buy — with more than 1,000 stores in the U.S. and Canada — would be able to deliver the dividend growth that it has of late?

In 2021, the company raised its quarterly dividend by 27% to 70 cents per share. Earlier this year, management announced another 26% quarterly payout increase to 88 cents per share.

While many retailers are still struggling, Best Buy has found its momentum. In the fiscal year ended Jan. 29, the company delivered record revenue and profitability, highlighted by 10.4% same-store sales growth.

The stock currently yields 4.1%. Goldman sees Best Buy continuing its dividend growth streak and offering a yield (based on the current price) of 4.3% in 2023.

Devon Energy (DVN)

With oil and gas prices shooting through the roof, energy stocks have become some of the healthiest dividend payers in the market.

Devon Energy, for instance, recently hiked its quarterly payout by 27% to a record high of $1.27 per share, giving the stock a mouth-watering annual yield of 7.6%. The board also increased the company’s share repurchase authorization by 25% to $2 billion.

In Q1, Devon generated $1.3 billion of free cash flow for the quarter, marking an 18% increase year over year.

Goldman expects prosperity to persist for the oil and gas producer, projecting a dividend yield of 7.8% in 2023 based on the current stock price. That said, it’s important to note that Devon’s dividend consists of a fixed quarterly payout and a variable dividend that includes up to 50% of excess free cash flow.

Sign up for our MoneyWise newsletter to receive a steady flow of actionable ideas from Wall Street's top firms.

Most people don't realize that with the right moves, you can become a millionaire — it's not a question of "if," it's a question of "when."

Read More

More from MoneyWise

Never overpay on Amazon again

Make sure to price-check online purchases with the help of Capital One Shopping. It’s totally free to use and takes less than a minute to set up.

Last year the service saved its customers over $160 million, and with just a few clicks you can start saving, too.

Download Capital One Shopping today and stop paying more than you have to for the exact same stuff.

About the Author

Jing Pan

Jing Pan

Investment Reporter

Jing is an investment reporter for MoneyWise. Prior to joining the team, he was a research analyst and editor at one of the leading financial publishing companies in North America. An avid advocate of investing for passive income, he wrote a monthly dividend stock newsletter for the better half of the past decade. Jing holds a Master’s Degree in Economics and an Honours Bachelor of Science Degree, both from the University of Toronto.

Disclaimer

The content provided on MoneyWise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter.